Drug name - Prialt

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8653033 TERSERA Method for administering omega-conopeptide
Oct, 2024

(1 year, 9 months from now)

US8765680 TERSERA Method for administering omega-conopeptide
Oct, 2024

(1 year, 9 months from now)

US9707270 TERSERA Method for administering ω-conopeptide
Oct, 2024

(1 year, 9 months from now)

Drugs and Companies using ZICONOTIDE ACETATE ingredient

Market Authorisation Date: 28 December, 2004

Treatment: Analgesia; Treatment of pain; Treatment of severe chronic pain via intrathecal infusion of ziconotide in patients also receiving morphine

Dosage: INJECTABLE;INTRATHECAL

More Information on Dosage
Strength Dosage Availability
100MCG/1ML (100MCG/ML) INJECTABLE;INTRATHECAL Prescription
200MCG/2ML (100MCG/ML) INJECTABLE;INTRATHECAL Discontinued
500MCG/20ML (25MCG/ML) INJECTABLE;INTRATHECAL Prescription
500MCG/5ML (100MCG/ML) INJECTABLE;INTRATHECAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.